Trials
Search / Trial NCT05642923

Post-COVID-19 Chronic Fatigue Syndrome

Launched by CLINAMYGATE · Dec 7, 2022

Trial Information

Current as of February 05, 2025

Active, not recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a condition known as Post-COVID-19 Chronic Fatigue Syndrome, which affects people who have previously been infected with the virus that causes COVID-19. Many individuals report feeling extremely tired for a long time after recovering from the virus, and this trial aims to understand and address that ongoing fatigue.

The trial is currently recruiting participants who are 18 years or older, regardless of gender, and who are experiencing fatigue after COVID-19. If you or someone you know fits this description and is interested in participating, you could help researchers learn more about this condition. Participants can expect to engage in assessments and activities related to their fatigue, which may contribute to better treatments in the future. It's important to note that if someone chooses not to participate, that’s perfectly fine and will not affect their care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age . 18
  • Male or female
  • Post-Covid-19 Fatigue
  • Exclusion Criteria:
  • refusal

About Clinamygate

Clinamygate is a leading clinical trial sponsor dedicated to advancing medical research and innovation through the development and management of comprehensive clinical studies. With a focus on enhancing patient outcomes and accelerating the drug development process, Clinamygate collaborates with a diverse range of stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. Our commitment to ethical practices and regulatory compliance ensures the highest standards of safety and efficacy in all trials. By leveraging cutting-edge technologies and a robust network of clinical sites, Clinamygate aims to bring transformative therapies to market efficiently and effectively, ultimately improving global health.

Locations

Maadi, Cairo, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials